{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T14:22:18Z","timestamp":1778682138371,"version":"3.51.4"},"reference-count":33,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2014,3,25]],"date-time":"2014-03-25T00:00:00Z","timestamp":1395705600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0092869","type":"journal-article","created":{"date-parts":[[2014,3,25]],"date-time":"2014-03-25T17:17:21Z","timestamp":1395767841000},"page":"e92869","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":7,"title":["A Transgenic Platform for Testing Drugs Intended for Reversal of Cardiac Remodeling Identifies a Novel 11\u03b2HSD1 Inhibitor Rescuing Hypertrophy Independently of Re-Vascularization"],"prefix":"10.1371","volume":"9","author":[{"given":"Oren","family":"Gordon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiheng","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Gilon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Gruener","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sherrie","family":"Pietranico-Cole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amit","family":"Oppenheim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eli","family":"Keshet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,3,25]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.carpath.2004.12.002","article-title":"Cardiac remodeling and failure: From molecules to man (Part I)","volume":"14","author":"PWM Fedak","year":"2005","journal-title":"Cardiovascular Pathology"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S0140-6736(06)68074-4","article-title":"Controversies in ventricular remodelling","volume":"367","author":"LH Opie","year":"2006","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1152\/physrev.1999.79.1.215","article-title":"Molecular Mechanisms of Myocardial Remodeling","volume":"79","author":"B Swynghedauw","year":"1999","journal-title":"Physiol Rev"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0735-1097(99)00630-0","article-title":"Cardiac remodeling\u2014concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling","volume":"35","author":"JN Cohn","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/nrcardio.2011.172","article-title":"Reverse remodeling in heart failure- mechanisms and therapeutic opportunities","volume":"9","author":"N Koitabashi","year":"2012","journal-title":"Nat Rev Cardiol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1146\/annurev.ph.57.030195.004105","article-title":"Angiotensin-converting enzyme inhibition and ventricular remodeling after myocardial infarction","volume":"57","author":"J Pfeffer","year":"1995","journal-title":"Annu Rev Physiol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.ehj.2004.06.003","article-title":"Expert consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease. The Task Force on ACE-inhibitors of the European Society of Cardiology","volume":"25","author":"J Lopez-Sendon","year":"2004","journal-title":"Eur Heart J"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJM199209033271001","article-title":"Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators","volume":"327","author":"M Pfeffer","year":"1992","journal-title":"N Engl J Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.cardiores.2006.08.023","article-title":"The PPAR regulatory system in cardiac physiology and disease","volume":"73","author":"BN Finck","year":"2007","journal-title":"Cardiovasc Res"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1161\/01.CIR.0000039346.31538.2C","article-title":"Pioglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates left ventricular remodeling and failure after experimental myocardial infarction","volume":"106","author":"T Shiomi","year":"2002","journal-title":"Circulation"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vascn.2007.01.003","article-title":"Rodent models of heart failure","volume":"56","author":"P Balakumar","year":"2007","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"497841","DOI":"10.1155\/2011\/497841","article-title":"Animal models of cardiovascular diseases","volume":"2011","author":"C Zaragoza","year":"2011","journal-title":"J Biomed Biotechnol"},{"key":"ref13","first-page":"257","article-title":"Isoproterenol-Induced Heart Necrosis, an Experimental Model for the Study of Angina Pectoris and Myocardial Infarct","volume":"22","author":"G Zbinden","year":"1963","journal-title":"Rev Can Biol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1161\/01.RES.44.4.503","article-title":"Myocardial infarct size and ventricular function in rats","volume":"44","author":"M Pfeffer","year":"1979","journal-title":"Circ Res"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1172\/JCI24682","article-title":"Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure","volume":"115","author":"I Shiojima","year":"2005","journal-title":"The Journal of Clinical Investigation"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/nrd3431","article-title":"Novel therapeutic targets for the treatment of heart failure","volume":"10","author":"J Tamargo","year":"2011","journal-title":"Nat Rev Drug Discov"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1073\/pnas.0707778105","article-title":"Transgenic system for conditional induction and rescue of chronic myocardial hibernation provides insights into genomic programs of hibernation","volume":"105","author":"D May","year":"2008","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Gordon O, Gilon D, He Z, May D, Lazarus A, <etal>et al<\/etal>.. (2012) VEGF-induced neovascularization rescues cardiac function but not adverse remodeling at advanced ischemic heart disease Arteriosclerosis, Thrombosis, and Vascular Biology.","DOI":"10.1161\/ATVBAHA.112.248674"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.drudis.2007.06.001","article-title":"Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 as a promising therapeutic target","volume":"12","author":"M Wamil","year":"2007","journal-title":"Drug Discov Today"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/cvr\/cvq149","article-title":"Improved heart function follows enhanced inflammatory cell recruitment and angiogenesis in 11betaHSD1-deficient mice post-MI","volume":"88","author":"S McSweeney","year":"2010","journal-title":"Cardiovasc Res"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"12165","DOI":"10.1073\/pnas.0500641102","article-title":"Preventing local regeneration of glucocorticoids by 11beta-hydroxysteroid dehydrogenase type 1 enhances angiogenesis","volume":"102","author":"G Small","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1161\/01.RES.79.4.691","article-title":"Conditional Transgene Expression in the Heart","volume":"79","author":"Z Yu","year":"1996","journal-title":"Circ Res"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0894-7317(89)80014-8","article-title":"Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms","volume":"2","author":"N Schiller","year":"1989","journal-title":"J Am Soc Echocardiogr"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1161\/HYPERTENSIONAHA.108.116350","article-title":"Renin inhibition improves cardiac function and remodeling after myocardial infarction independent of blood pressure","volume":"52","author":"D Westermann","year":"2008","journal-title":"Hypertension"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.yjmcc.2008.03.021","article-title":"The PPAR trio: regulators of myocardial energy metabolism in health and disease","volume":"44","author":"J Madrazo","year":"2008","journal-title":"J Mol Cell Cardiol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1161\/01.RES.0000179226.34112.6d","article-title":"Cardiomyocyte-Specific Knockout and Agonist of Peroxisome Proliferator\u2013Activated Receptor-\u03b3 Both Induce Cardiac Hypertrophy in Mice","volume":"97","author":"SZ Duan","year":"2005","journal-title":"Circulation Research"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.cardiores.2006.02.010","article-title":"Cross talk between corticosteroids and alpha-adrenergic signalling augments cardiomyocyte hypertrophy: a possible role for SGK1","volume":"70","author":"K Lister","year":"2006","journal-title":"Cardiovasc Res"},{"key":"ref28","first-page":"339","article-title":"Isoproterenol-induced myocardial injury and diastolic dysfunction in mice: structural and functional correlates","volume":"59","author":"WW Brooks","year":"2009","journal-title":"Comp Med"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/cvr\/cvr067","article-title":"Angiotensin II increases periostin expression via Ras\/p38 MAPK\/CREB and ERK1\/2\/TGF-\u03b21 pathways in cardiac fibroblasts","volume":"91","author":"L Li","year":"2011","journal-title":"Cardiovascular Research"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.yjmcc.2009.07.015","article-title":"The extracellular matrix as a modulator of the inflammatory and reparative response following myocardial infarction","volume":"48","author":"M Dobaczewski","year":"2010","journal-title":"Journal of Molecular and Cellular Cardiology"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.yjmcc.2007.07.045","article-title":"Factors controlling cardiac myosin-isoform shift during hypertrophy and heart failure","volume":"43","author":"M Gupta","year":"2007","journal-title":"J Mol Cell Cardiol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1093\/eurheartj\/ehq522","article-title":"Effect of the direct renin inhibitor aliskiren on left ventricular remodelling following myocardial infarction with systolic dysfunction","volume":"32","author":"SD Solomon","year":"2011","journal-title":"European Heart Journal"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.cardfail.2011.09.002","article-title":"Angiotensin-Converting Enzyme Inhibition Promotes Coronary Angiogenesis in the Failing Heart of Dahl Salt-Sensitive Hypertensive Rats","volume":"17","author":"H Yazawa","year":"2011","journal-title":"Journal of Cardiac Failure"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0092869","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T18:35:19Z","timestamp":1565289319000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0092869"}},"subtitle":[],"editor":[{"given":"Patrick CH.","family":"Hsieh","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,3,25]]},"references-count":33,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2014,3,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0092869","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,25]]}}}